Abbott Labs (ABT) reported third-quarter 2016 earnings of 59 cents per share, beating the Zacks Consensus Estimate of a loss of 58 cents.
Roche's (RHHBY) immuno-oncology drug, Tecentriq, has gained FDA approval for the treatment of a specific type of metastatic lung cancer.
- Zacks•2 days ago
Shares of Regeneron (REGN) and Teva (TEVA) were hit after the FDA placed the chronic low back pain study evaluating fasinumab on clinical hold.
Incyte Corporation (INCY)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||88.37 x 100|
|Ask||88.47 x 100|
|Day's Range||87.10 - 90.11|
|52wk Range||55.00 - 124.98|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||241.39|
|Avg Vol (3m)||1,323,996|
|Dividend & Yield||N/A (N/A)|